V002-2653 Screening compound: N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide

V002-2653 Screening compound: N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide
V002-2653 Screening compound: N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V002-2653
N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V002-2653

Molecular Formula

C28H32N2O5S2 (C28 H32 N2 O5 S2)

Compound Name

N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H,5H,6H,7H-thieno[3,2-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide

IUPAC name

N-(cyclopropylmethyl)-N-(2-{4-[(3-methoxyphenoxy)methyl]-4H5H6H7H-thieno[32-c]pyridin-5-yl}-2-oxoethyl)-4-methylbenzene-1-sulfonamide

SMILES

Cc(cc1)ccc1S(N(CC1CC1)CC(N(CC1)C(COc2cc(OC)ccc2)c2c1scc2)=O)(=O)=O

InChI

InChI=1S/C28H32N2O5S2/c1-20-6-10-24(11-7-20)37(32,33)29(17-21-8-9-21)18-28(31)30-14-12-27-25(13-15-36-27)26(30)19-35-23-5-3-4-22(16-23)34-2/h3-7,10-11,13,15-16,21,26H,8-9,12,14,17-19H2,1-2H3/t26-/m0/s1

InChI Key

VYSNVKFSKRPTCL-SANMLTNESA-N

MDL Number (MFCD)

MFCD19867867

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

540.7

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.558

Distribution Coefficient, logD

5.558

Water Solubility, LogSw

-5.39

Polar Surface Area

63.246

Acid Dissociation Constant (pKa)

23.06

Base Dissociation Constant (pKb)

-1.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

39.30

V002-2653 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V002-2653 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V002-2653?
Check Price and Availability of V002-2653, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V002-2653 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V002-2653
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V002-2653
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V002-2653 available by request